Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Survival Outcomes in Cervical Cancer SENTICOL with Patrice Mathevet

Survival Outcomes in Cervical Cancer SENTICOL with Patrice Mathevet

FromIJGC Podcast


Survival Outcomes in Cervical Cancer SENTICOL with Patrice Mathevet

FromIJGC Podcast

ratings:
Length:
19 minutes
Released:
Mar 4, 2019
Format:
Podcast episode

Description

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Patrice Mathevet from the University of Lausanne in Switzerland. Dr. Mathevet is the author of the Lead Article for the March 2019 issue, "Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial." They discuss the aim and results of the study, as well as the implications for future treatment.
Released:
Mar 4, 2019
Format:
Podcast episode

Titles in the series (100)

From June 2023, all our podcasts will move to https://ijgcbmj.podbean.com. You can continue with your subscription on your favourite podcast App. The International Journal of Gynecological Cancer publishes content on novel and relevant topics in the field of gynecologic cancer. IJGC Podcast features short interview segments with leading experts discussing the latest research in their respective areas. The podcasts will serve as an interactive and education experience for all our listeners. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.